AstraZeneca Pharma India Slapped Rs 11.88 Cr Tax Adjustment for FY23, to Move ITAT
New Delhi: AstraZeneca Pharma India Limited has received a final assessment order from the Assessment Unit of the Income Tax Department for the assessment year 2022-23, involving proposed adjustments related…